跳至主要内容
临床试验/JPRN-UMIN000002101
JPRN-UMIN000002101未知2 期

iver resection after chemotherapy for liver only metastasis from colorectal cancer - Liver resection after chemotherapy for liver only metastasis from colorectal cancer

Tokyo Medical & Dental University0 个研究点目标入组 70 人开始时间: 2009年6月22日最近更新:
适应症

试验速览

阶段
2 期
发起方
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1) Transfusion or blood product or growth factor such as G-CSF less than 7 days prior to entry (2) Prior severe drug allergy (3) Radiotherapy less than 4 weeks prior to entry (4) Chronic daily treatment with anti-platelet drug such as high dose aspirin (more than 325mg/day) or other NSAID (temporary use of NSAIDs for cancer pain are permitted) (5) Presence of cerebrovascular disease or symptoms less than 1 year prior to entry (6) Presence of uncontrolled pleural effusion or ascites (7) Presence of cardiac effusion (8) Presence of active infection (9) Presence of viral hepatitis (10) Other active malignancy or multiple colorectal cancers (11) Severe postoperative complications(e.g. postoperative infection, anastomotic dehiscence,or paralytic ileus) (12) Uncontrolled co-mobility, such as hypertension, diabetes, arrhythmia, or other medical conditions (13) Hemorrhage/bleeding,paralytic ileus, obstruction, or ulceration of gastrointestinal tract (14) Perforation of gastrointestinal tract less than 1 year prior to entry (15) Grade 2 diarrhea or sensory neuropathy (16) Chronic systemic treatment of corticosteroid (17) Phenytoin, Warfarin potassium, or flucytosin administration (18) Surgery, biopsy with skin incision, or traumatic injury with suture less than 4 weeks prior to entry (19) Nursing or pregnant females, or females or males with female partners who are planning to pregnancy (20) Participation in other clinical trial (21) Any other serious medical condition that would preclude study treatment

研究者

发起方
Tokyo Medical & Dental University

相似试验